SANDSIV Named Gold Medallist and Leader in the 2022 SoftwareReviews VOC Data Quadrant
Customers have spoken: sandsiv+ is rated #1 Voice of the Customer (VOC) software in the…
News
PacBio Opens European Headquarters in London
PacBio Logo in New London Office PacBio opens new office in London. Company Announces New…
TransCode Therapeutics Announces Article Published in the Journal Cancers Detailing the Potential for Short RNA-based Drugs in Cancer and a Broad Range of Disorders
BOSTON, March 23, 2022 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology…
Novolyze Raises $15 Million to Improve Food Safety Globally
BETHESDA, Md., March 23, 2022 (GLOBE NEWSWIRE) — Bethesda, Maryland- and Dijon, France-based food safety…
Panbela to Participate in a Panel Discussion: “Pancreatic Cancer- Turning the Tide for One of the Most Challenging Indications in Oncology,” at the Maxim Virtual Growth Conference on March 28, 2022, at 12:00 pm ET
MINNEAPOLIS, March 23, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical…
Allogene Therapeutics Announces Preclinical Publication Highlighting Superiority of Healthy Donor-Derived Allogeneic CAR T Cells Over Patient-Derived Cells in Multiple Myeloma
Results Demonstrated Anti-BCMA CAR T Cells Derived from Healthy Donors Had Better Immune Fitness and…
Heat Biologics Announces Appointment of Greg Burel, Former Director of the Strategic National Stockpile, to its Biothreat Advisory Board and as Senior Advisor to the Company
Burel to support anthrax and RapidVax™ biodefense initiatives as a platform for rapid response to…
Atreca to Host Virtual R&D Day on Tuesday, April 5, 2022
SAN CARLOS, Calif., March 23, 2022 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a…
TRACON Pharmaceuticals to Present at the Maxim Group 2022 Virtual Growth Conference
SAN DIEGO, March 23, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage…
AIM ImmunoTech to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest
Company to participate in live panel, “Pancreatic Cancer: Turning the Tide for One of the…
ARECOR GRANTED KEY U.S. PATENT PROTECTING PROPRIETARY INSULIN PRODUCTS
Arecor Therapeutics plc(“Arecor” or the “Group”) ARECOR GRANTED KEY U.S. PATENT PROTECTING PROPRIETARY INSULIN PRODUCTS…
RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol
Glen Rock, N.J., March 23, 2022 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or…
Rani Therapeutics Announces Initiation of Phase 1 Study of RT-102 Oral PTH for Osteoporosis
SAN JOSE, Calif., March 23, 2022 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…
Histogen Announces $4.75 Million Private Placement
SAN DIEGO, March 23, 2022 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage company…
Kala Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call
ARLINGTON, Mass., March 23, 2022 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical…
Ventyx Biosciences Reports Full Year 2021 Financial Results and Highlights Recent Corporate Progress
Topline Phase 1 data for our allosteric TYK2 inhibitor, VTX958, expected in early Q3 2022…
Vallon Pharmaceuticals to Participate at the 5th Annual Neuroscience Innovation Forum
David Baker, President and CEO of Vallon to participate in the virtual Advances in Neuropsychiatry…
Synthetic Biologics Announces Management Transitions in Support of Strategic Transformation
-Frank Tufaro, Ph.D., appointed as Chief Operating Officer of Synthetic Biologics, transitioning from Chief Operating…
AccuStem Sciences, Inc. Announces DTC Eligibility
LONDON and PHOENIX, March 23, 2022 (GLOBE NEWSWIRE) — AccuStem Sciences, Inc. (OTC Pink: ACUT),…
Ocugen Announces Appointment of Marna C. Whittington, PhD, to Board of Directors
MALVERN, Pa., March 23, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage biotechnology company…